Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma
Heike Niessner(University of Tübingen), Tobias Sinnberg(University Children's Hospital Tübingen)
Cited by 3
Related Papers
Targeting hyperactivation of the <scp>AKT</scp> survival pathway to overcome therapy resistance of melanoma brain metastases
|Cancer Medicine|2012|152
β-Catenin Signaling Increases during Melanoma Progression and Promotes Tumor Cell Survival and Chemoresistance
|PLoS ONE|2011|108
Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype
|Molecular Cancer|2018|78